The US FDA has approved IntraBio for the treatment of a rare genetic disease

The U.S. Food and Drug Administration has approved a drug from IntraBio to treat a rare and deadly genetic disease, the health regulator said Tuesday, just days after the agency approved the first treatment for the condition.

Teile diesen Beitrag:

BELIEBTE BEITRÄGE
FOLGEN SIE UNS
Like uns auf Facebook
Folge uns auf Twitter
Abonniere unseren Kanal
Tick Tack
LIVEÜBERTRAGUNG